Like Shingrix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Curevo Vaccine Announces Positive Topline Results from

Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune.

United statesWilliam smithGeorge simeonAlliance for multispecialty researchVaccine response rateGuy de la rosaChief medicalMultispecialty researchChief executive officerLike shingrixCurevo vaccineHerpes zoster

Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs Shingrix

Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs Shingrix
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesDavid millerWilliam smithGeorge simeonStrategic communicationsAlliance for multispecialty researchVaccine announces positive topline resultsNext generation vaccineVaccine response rateGuy de la rosaChief medicalMultispecialty researchChief executive officerLike shingrix